Home › NDC Lookup › RxCUI directory › RxCUI 1536586

168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [... — RxCUI 1536586

RxNorm drug concept · Semantic branded drug
RxCUI 1536586 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1536586
Official name168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Xulane]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXulane 150/35 MCG/Day Weekly Transdermal System; Xulane (ethinyl estradiol 35 MCG / norelgestromin 150 MCG per 24HR) 7 Day Transdermal Patch
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)242,059 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ethinyl Estradiol / Norelgestromin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, exactly every week for 3 weeks in a row, then you skip week 4 entirely — no patch. Always change it on the same day each week (your 'Patch Change Day'). Only wear one patch at...
  • How exactly do I use the patch — do I really have to change it every week?
  • You can apply it to your upper outer arm, abdomen, buttock, or back. Just avoid the breast. Absorption is considered equivalent from all those spots, though the abdomen absorbs sli...
  • Where should I put the patch on my body?
📖 Read our full Ethinyl Estradiol / Norelgestromin guide →

🕸️ Concept Web — How 168 HR ethinyl estradiol 0.00146 MG/HR / norelge... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Xulane] RxCUI 1536586

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Norelgestromin 326374
    • Ethinyl estradiol / norelgestromin 352377
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xulane 1536581
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / norelgestromin Transdermal System 1806237
    • Ethinyl estradiol / norelgestromin Topical Product 1157362
    • Ethinyl estradiol / norelgestromin Transdermal Product 1295056
    • Ethinyl estradiol / norelgestromin Transdermal System [Xulane] 1806243
    • Xulane Topical Product 1536584
    • Xulane Transdermal Product 1536585
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR [Xulane] SBDC · 1536582
  • Ethinyl estradiol / norelgestromin Transdermal System [Xulane] SBDF · 1806243
  • Xulane Topical Product SBDG · 1536584
  • Xulane Transdermal Product SBDG · 1536585
  • Xulane BN · 1536581

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1536586 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-3340-53 3 POUCH in 1 CARTON (0378-3340-53) / 1 PATCH in 1 POUCH (03... XULANE Mylan Pharmaceuticals Inc. 2014-04-16
50090-1683-00 3 POUCH in 1 CARTON (50090-1683-0) / 1 d in 1 POUCH XULANE A-S Medication Solutions 2015-02-06
Observed labelers: A-S Medication Solutions (1) · Mylan Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$37.6366
Range $37.6366–$37.6366 · middle 50% $37.6366–$37.6366 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.